Latest Articles

Publication Date
Integrated Bioinformatics and Experimental Analysis Revealed Crosstalk Between IL-6, Autophagy, Ubiquitination, and Key miRNAs in Female Infertility: Insights from Ovarian Endometriosis and Polycystic Ovary Syndrome.

Female infertility, affecting millions worldwide, involves complex molecular mechanisms such as chronic inflammation, impaired cellular death, and protein regulation. This study explores how the cytokine IL-6, the autophagy marker LC3, …

Published: Oct. 28, 2025, midnight
Bayer’s New Study on Mirena: A Potential Game-Changer for Endometrial Hyperplasia Treatment - TipRanks

Bayer’s New Study on Mirena: A Potential Game-Changer for Endometrial Hyperplasia Treatment TipRanks

Published: Oct. 27, 2025, 11:58 p.m.
Genmab’s New Phase 3 Study: A Potential Game-Changer in Endometrial Cancer Treatment - TipRanks

Genmab’s New Phase 3 Study: A Potential Game-Changer in Endometrial Cancer Treatment TipRanks

Published: Oct. 27, 2025, 11:43 p.m.
BioNTech’s Promising Phase III Trial: A Potential Game-Changer in Endometrial Cancer Treatment - TipRanks

BioNTech’s Promising Phase III Trial: A Potential Game-Changer in Endometrial Cancer Treatment TipRanks

Published: Oct. 27, 2025, 10:53 p.m.
Iovance Biotherapeutics Advances in Endometrial Cancer Treatment with Lifileucel Study - TipRanks

Iovance Biotherapeutics Advances in Endometrial Cancer Treatment with Lifileucel Study TipRanks

Published: Oct. 27, 2025, 10:21 p.m.
EDAP TMS S.A. Advances HIFU Treatment Study for Rectal Endometriosis - TipRanks

EDAP TMS S.A. Advances HIFU Treatment Study for Rectal Endometriosis TipRanks

Published: Oct. 27, 2025, 9:42 p.m.
Acrivon Therapeutics Advances Phase 2 Study for Endometrial Cancer Treatment - TipRanks

Acrivon Therapeutics Advances Phase 2 Study for Endometrial Cancer Treatment TipRanks

Published: Oct. 27, 2025, 9:13 p.m.
Kissei Pharmaceutical’s Promising Phase III Study on Endometriosis Treatment - TipRanks

Kissei Pharmaceutical’s Promising Phase III Study on Endometriosis Treatment TipRanks

Published: Oct. 27, 2025, 6:32 p.m.
Hutchmed’s Promising Phase III Study on Advanced Endometrial Cancer Treatment - TipRanks

Hutchmed’s Promising Phase III Study on Advanced Endometrial Cancer Treatment TipRanks

Published: Oct. 27, 2025, 5:04 p.m.
The Nexus of Iron, Senescence, and Fibrosis in Endometriosis: A Narrative Review.

Endometriosis is a prevalent chronic inflammatory condition impacting 5-10% of reproductive-age women, commonly resulting in debilitating pelvic pain and infertility. Despite extensive research efforts, the precise underlying pathophysiology remains largely …

Published: Oct. 27, 2025, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!